AbCellera Biologics Inc (STU:8QQ)
€ 2.727 -0.015 (-0.55%) Market Cap: 793.79 Mil Enterprise Value: 210.54 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 59/100

Abcellera Biologics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 03:30PM GMT
Release Date Price: €12.35 (-3.89%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Welcome, everyone, to Credit Suisse's 30th Annual Healthcare Conference. I'm Tiago Fauth. I'm a biotech analyst here at Credit Suisse, and we're joined today by AbCellera. We have Carl Hansen, CEO, for a fireside chat. Happy to ask any questions on your behalf and try to work those in, in our fireside chat. The e-mail is T-I-A-G-O dot F-A-U-T-H @ credit-suisse. Happy to try to address some those.

Questions & Answers

Tiago Felipe Fauth;dit Suisse AG;Carl L.G. Hansen
CrÃ;Research Division - Research Analyst;

© -

But Carl, as usual, we generally like to start with a brief overview, and you just reported earnings fairly recently with some fairly impressive results from an operations perspective. Can you just kind of briefly recap the AbCellera story and the progress you've made since you've gone public almost a year ago now, right? That's -- it feels like it's only yesterday so...

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot